XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,571,120 | -11.6% | 192,363 | -0.3% | 0.02% | -8.0% |
| Q2 2023 | $7,431,848 | +9.1% | 193,035 | +1.4% | 0.02% | +8.7% |
| Q1 2023 | $6,813,700 | -9.4% | 190,380 | -0.2% | 0.02% | -14.8% |
| Q4 2022 | $7,523,007 | -45.7% | 190,794 | -50.3% | 0.03% | 0.0% |
| Q3 2022 | $13,850,280 | +19.0% | 383,672 | +0.3% | 0.03% | +22.7% |
| Q2 2022 | $11,641,897 | -2.4% | 382,702 | -1.9% | 0.02% | +29.4% |
| Q1 2022 | $11,925,740 | +95.7% | 390,104 | +100.0% | 0.02% | +6.2% |
| Q4 2021 | $6,093,000 | +149.8% | 195,048 | +22.2% | 0.02% | +128.6% |
| Q3 2021 | $2,439,000 | – | 159,643 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |